{"type":"rich","title":"Workplace Strategies Watercooler 2026: What the DOJ\u2019s Medical Marijuana Reclassification Means for Employers","version":"1.0","provider_name":"Blubrry","provider_url":"https://blubrry.com","author_name":"Ogletree Deakins Podcasts","html":"<iframe src=\"https://player.blubrry.com/?podcast_id=153946312\" title=\"Blubrry Podcast Player\" scrolling=\"no\" width=\"100%\" height=\"230\" frameborder=\"0\"></iframe>","height":"230","description":"The Department of Justices reclassification of certain marijuana products from Schedule I to Schedule III marks a significant shift in federal drug policy, and employers are now facing new questions about how to respond. In this installment of our Workpl","thumbnail_url":"http://ogletreedeakinspodcasts.blubrry.net/wp-content/uploads/powerpress/Ogletree_Deakins_Podcasts_1.jpg"}